Study of haemostasis in depressive patients treated with fluoxetine

Pharmacoepidemiology and Drug Safety

Volumn 7, Issue SUPPL. 1, 1998, Pages

  Lainé Cessac, Pascale ^a   Shoaay, Iran ^b   Garre, Jean Bernard ^a   Glaud, Valerie ^a   Turcant, Alain ^a   Allain, Pierre ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Ctr Departemental Transfus Sang   (France)

Author keywords

Coagulation; Depression; Fluoxetine; Haemostasis; Platelet aggregation; Selective serotonin reuptake inhibitor

Indexed keywords

ADRENALIN; ALGESTONE; ARACHIDONIC ACID; BEZAFIBRATE; BIOTIN; BROMAZEPAM; COLLAGEN; ESTRADIOL; FLUOXETINE; JOSAMYCIN; LORAZEPAM; NICOTINE; NORFLUOXETINE; PARACETAMOL; PROPRANOLOL; RISTOCETIN; THIAMINE; TIAPRIDE; ZOLPIDEM; ZOPICLONE;

ADULT; AGED; BLEEDING TIME; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

EID: 0031830634     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199808)7:1+3.0.CO;2-Z     Document Type: Conference Paper

References (12)

1. Humphries, J. E., Wheby, M. S. and Vanden-Berg, S. R. Fluoxetine and the bleeding time. Archives of Pathology and Laboratory Medicine, 1990; 114: 727-728.
2. Yaryura-Tobias, J. A., Kirschen, H., Ninan, P. and Mosberg, H. J. Fluoxetine and bleeding in obsessive-compulsive disorder. American Journal of Psychiatry, 1991; 148: 949.
3. Aranth, J. and Lindberg, C. Bleeding, a side effect of fluoxetine. American Journal of Psychiatry, 1992; 149: 412.
4. Gunzberger, D. W. and Martinez, D. Adverse vascular effects associated with fluoxetine. American Journal of Psychiatry, 1992; 149: 1751.
5. Alderman, C. P., Moritz, C. K. and Ben-Tovim, D. I. Abnormal platelet aggregation associated with fluoxetine therapy. Annals of Pharmacotherapy, 1992; 26: 1517-1519.
6. Calhoun, J. W. and Calhoun, D. D. Prolonged bleeding time in a patient treated with sertraline. American Journal of Psychiatry, 1996; 153: 443.
7. Evans, T. G., Buys, S. S. and Rodgers, G. M. Acquired abnormalities of platelet function [letter]. New England Journal of Medicine, 1991; 324: 1671.
8. Horng, J. S. and Wong, D. T. Effects of serotonin uptake inhibitor, Lilly 110140, on transport of serotonin in rat and human blood platelets. Biochemical Pharmacology, 1976; 25: 865-867.
9. Berk, M., Jacobson, B. F. and Hurly, E. Fluoxetine and hemostatic function: a pilot study. Journal of Clinical Psychiatry, 1995; 56: 14-16.
10. Blockmans, D., Deckmyn, H. and Vermylen, J. Platelet activation. Blood Reviews, 1995; 9: 143-156.
11. Lanza, F., Beretz, A., Stierle, A., Hanau, D., Kubina, M. and Cazenave, J. P. Epinephrine potentiates human platelet activation but is not an aggregating agent. American Journal of Physiology, 1989; 255: H 1276-288.
12. Healy, D., Carney, P. A., O'Halloran, A. and Leonard, B. E. Peripheral adrenoreceptors and serotonin receptors in depression. Changes associated with response to treatment with trazodone or amitriptyline. Journal of Affective Diseases, 1985; 9: 285-296.